Trademark: 88837913
Status Date
Monday, December 20, 2021
Filing Date
Tuesday, March 17, 2020
Published for Opposition
Tuesday, September 22, 2020
Abandoned Date
Monday, December 20, 2021
1 Chemical agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for single-cell or single-organelle nucleic acid and protein indexing, sequencing and analysis for scientific and research use; Diagnostic reagents and preparations for single-cell or single-organelle nucleic acid and protein indexing, sequencing and analysis for scientific and research use; Diagnostic kits for scientific and research use containing nucleotides, reagents, enzyme substrates, buffers, chemical preparations, or biological preparations for single-cell or single-organelle nucleic acid and protein indexing, sequencing and analysis; nucleotides for medical research
5 Biological agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for single-cell or single-organelle nucleic acid and protein indexing, sequencing and analysis for medical and veterinary use; diagnostic reagents and preparations for single-cell or single-organelle nucleic acid and protein indexing, sequencing and analysis for medical and veterinary use; Diagnostic kits for medical genetic testing and medical diagnostic purposes containing medical diagnostic reagents, nucleotides, enzyme substrates, buffers, chemical preparations, biological preparations for single-cell or single-organelle nucleic acid and protein indexing, sequencing and analysis
42 Scientific research and analysis, namely, single-cell or single-organelle nucleic acid and protein indexing, sequencing and analysis services for scientific and research purposes; Providing online non-downloadable computer software for single-cell or single-organelle nucleic acid and protein indexing, sequencing and analysis in the fields of diagnostic research, clinical research, and medical laboratory research; Software as a service (SaaS) services featuring online non-downloadable computer software for indexing, sequencing, and analysis of single-cell or single-organelle nucleic acid and protein in the fields of diagnostic research, clinical research, and medical laboratory research; Providing online non-downloadable computer software for the custom design and ordering of assays, nucleic acids and reagents; Software as a service (SaaS) services, namely, hosting software for the custom design and purchasing of assays, nucleic acids and reagents
44 Medical testing for diagnostic or treatment purposes; Medical diagnostic services, namely, single-cell or single-organelle nucleic acid and protein indexing, sequencing, screening, and analysis services for medical diagnostic purposes
Dec 20, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 20, 2021
Abandonment - No Use Statement Filed
May 5, 2021
Notice Of Approval Of Extension Request E-Mailed
May 4, 2021
Extension 1 Granted
Apr 16, 2021
Extension 1 Filed
Apr 30, 2021
Case Assigned To Intent To Use Paralegal
Apr 16, 2021
Teas Extension Received
Apr 7, 2021
Automatic Update Of Assignment Of Ownership
Nov 17, 2020
Noa E-Mailed - Sou Required From Applicant
Sep 22, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 22, 2020
Published For Opposition
Sep 2, 2020
Notification Of Notice Of Publication E-Mailed
Aug 18, 2020
Approved For Pub - Principal Register
Aug 18, 2020
Examiner's Amendment Entered
Aug 18, 2020
Notification Of Examiners Amendment E-Mailed
Aug 18, 2020
Examiners Amendment E-Mailed
Aug 18, 2020
Examiners Amendment -Written
Aug 11, 2020
Teas/Email Correspondence Entered
Aug 10, 2020
Correspondence Received In Law Office
Aug 10, 2020
Teas Response To Office Action Received
Jun 19, 2020
Notification Of Priority Action E-Mailed
Jun 19, 2020
Priority Action E-Mailed
Jun 19, 2020
Priority Action Written
Jun 9, 2020
Assigned To Examiner
Mar 22, 2020
New Application Office Supplied Data Entered In Tram
Mar 20, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
